Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond

The recent FDA approval of the neurosteroid, brexanolone (allopregnanolone), as a treatment for women with postpartum depression, and successful trials of a related neuroactive steroid, SGE-217, for men and women with major depressive disorder offer the hope of a new era in treating mood and anxiety...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neurobiol Stress
Main Authors: Zorumski, Charles F., Paul, Steven M., Covey, Douglas F., Mennerick, Steven
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2019
Teme:
Articles from the Special Issue on Allopregnanolone role in the neurobiology of stress and mood disorders; Edited by Graziano Pinna
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804800/
https://ncbi.nlm.nih.gov/pubmed/31649968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ynstr.2019.100196
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki